JORGE E CORTES to Patient Selection
This is a "connection" page, showing publications JORGE E CORTES has written about Patient Selection.
Connection Strength
0.294
-
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia. Am J Hematol. 2021 04 01; 96(4):493-507.
Score: 0.108
-
Acute myeloid leukaemia. Lancet. 2018 08 18; 392(10147):593-606.
Score: 0.091
-
Considerations in the management of patients with Philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy. J Clin Oncol. 2011 Apr 20; 29(12):1512-6.
Score: 0.055
-
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Blood. 2003 May 15; 101(10):3794-800.
Score: 0.031
-
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood. 2004 Aug 01; 104(3):865-72.
Score: 0.008